SABR for Renal Cell Carcinoma Offers Excellent Outcomes
Stereotactic ablative radiotherapy (SABR) for patients with primary renal cell carcinoma (RCC) is well tolerated and is associated with excellent local oncologic control,... Read More
Day
January 12, 2018